S232: EXPANDING THE REPERTOIRE OF HLA CLASS I-RESTRICTED MINOR HISTOCOMPATIBILITY ANTIGENS FOR IMMUNE MONITORING AND MODULATION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
作者
K. Fuchs,Marian van de Meent,Wilhelmina M. Honders,Cornelis A.M. van Bergen,J.H. Frederik Falkenburg,Marieke Griffioen
Background: Allogeneic stem cell transplantation is given as curative treatment for hematological malignancies, but patients face the risk of relapse of their malignancy as well as Graft-versus-Host Disease. After transplantation, donor T cells recognize polymorphic peptides presented by HLA surface molecules on the patient’s cells. These polymorphic peptides, called minor histocompatibility antigens, are caused by genetic differences in single nucleotide polymorphisms (SNPs) between patient and donor. Dependent on whether the antigen is presented on tumor cells or healthy non-hematopoietic tissues of the patient, donor T cells may induce the favourable Graft-versus-Leukemia effect or Graft-versus-Host-Disease, respectively. Aims: The aim is to identify the dominant repertoire of minor histocompatibility antigens in seven common HLA class I molecules for immune monitoring and modulation after allogeneic stem cell transplantation. Methods: Donor T cells isolated from patients after allogeneic stem cell transplantation are tested for recognition of a new panel of 191 selected B cell lines, which are sequenced in the 1000 Genomes Project. This panel enables the inclusion of seven common HLA class I molecules and increases SNP coverage to 11 million (MAF > 0.01). SNPs that strongly associate with T cell recognition are subsequently validated to encode minor histocompatibility antigens. Results: Using an optimized approach for whole genome association scanning, more than 80 new minor histocompatibility antigens have been found that are presented by seven common HLA class I molecules. Antigens targeted in immune responses after transplantation were often shared between patients, and about 25-30% of antigens were translated in other reading frames than human proteins with known function. Furthermore, the extended repertoire was investigated for T cell frequency and tissue distribution of antigen-encoding genes, pointing towards several antigens as potential targets for immunotherapy. Summary/Conclusion: In conclusion, despite many SNP mismatches between patients and donors, our data demonstrate that the repertoire of minor histocompatibility antigens is confined. As the antigens were identified by an unbiased forward strategy (T cell-to-antigen), our collection provides relevant insight into the various sources of antigens in annotated and unannotated reading frames, which is essential for accurate antigen prediction by reverse strategies (antigen-to-T cell). Furthermore, we more than doubled the number of minor histocompatibility antigens which are fundamental to predict, follow or manipulate immune responses after allogeneic stem cell transplantation to improve clinical outcome of transplanted patients.